Lanreotide in the prevention and management of high-output ileostomy after colorectal cancer surgery

Objective: Patients with stage III and high-risk stage II colorectal cancer (CRC) are advised to initiate adjuvant treatment as soon as feasible and certainly before 8 to 12 weeks after resection of the tumor. A protective ileostomy is often constructed during surgery to protect a primary anastomosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuyle, Pieter-Jan, Engelen, Anke, Moons, Veerle, Tollens, Tim, Carton, Saskia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990955/
https://www.ncbi.nlm.nih.gov/pubmed/29888099
http://dx.doi.org/10.1080/21556660.2018.1467916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990955/
https://www.ncbi.nlm.nih.gov/pubmed/29888099
http://dx.doi.org/10.1080/21556660.2018.1467916

Ejemplares similares